Christopher van Dyck MD
Professor of Psychiatry, Neurology, and Neurobiology; Director, Alzheimer's Disease Research Unit
Departments & Organizations

Biological and Biomedical Sciences (BBS): Neuroscience
Interdepartmental Neuroscience Program
Yale Medical Group
Neurobiology
Neurology
Dorothy Adler Geriatric Assessment Center
Psychiatry: Alzheimer's Disease Research Unit | Clinical Research Patient Care | Division of Aging & Geriatric Psychiatry
Research Interests
Alzheimer's disease; Healthy aging; Cognitive aging; Pharmacotherapy; Neuroimaging; Genetics more...
Education
- B.A., Yale University, 1978
- M.D., Northwestern University, 1984
Selected Publications
- Mitsis EM, Cosgrove KP, Staley JK, Bois F, Frohlich EB, Tamagnan GD, Estok KM, Seibyl JP, van Dyck CH. Age-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT. Neurobiol Aging 2009;30(9):1490-7.
- Santhosh L, Estok KM, Vogel RS, Tamagnan GD, Baldwin RM, Mitsis EM, MacAvoy MG, Staley JK, van Dyck CH. Regional distribution and behavioral correlates of 5-HT2A receptors in Alzheimer’s disease with [18F]deuteroaltanserin and PET. Psychiatry Res Neuroimaging 2009;173:212-7.
- van Dyck CH, Avery RA, MacAvoy MG, Marek KL, Quinlan DM, Baldwin RM, Seibyl JP, Innis RB, Arnsten AFT. Striatal dopamine transporters correlate with simple reaction time in elderly subjects. Neurobiol Aging 2008;29(8):1237-46.


